{"id":115904,"date":"2020-11-15T12:22:19","date_gmt":"2020-11-15T20:22:19","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2020\/11\/scientists-develop-next-generation-immunotherapy-now-entering-early-phase-clinical-trials"},"modified":"2020-11-15T12:22:19","modified_gmt":"2020-11-15T20:22:19","slug":"scientists-develop-next-generation-immunotherapy-now-entering-early-phase-clinical-trials","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2020\/11\/scientists-develop-next-generation-immunotherapy-now-entering-early-phase-clinical-trials","title":{"rendered":"Scientists develop next-generation immunotherapy now entering early phase clinical trials"},"content":{"rendered":"<p><\/p>\n<p><iframe style=\"display: block; margin: 0 auto; width: 100%; aspect-ratio: 4\/3; object-fit: contain;\" src=\"https:\/\/www.youtube.com\/embed\/k41b40XYbXw?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; encrypted-media; gyroscope;\n   picture-in-picture\" allowfullscreen><\/iframe><\/p>\n<p>Cancer Research UK scientists have invented a new experimental drug that aims to harness the full power of the body\u2019s own immune system, launching a two-pronged response against cancer, according to a study published in <i>Nature Cancer<\/i> today.<\/p>\n<p>In the study, partly funded by Cancer Research UK, the new immunotherapy <a href=\"https:\/\/medicalxpress.com\/tags\/drug\/\" rel=\"tag\" class=\"\">drug<\/a>, which targets suppressive \u2018regulatory\u2019 immune cells inside a tumor, significantly improved long-term survival in animal models even when used without other drugs.<\/p>\n<p>If this, and larger follow-up trials, are successful, it could lead to a new immunotherapy treatment for people with high numbers of a certain type of immune cell that are found in cancers including melanoma, some lung cancers and head and neck <a href=\"https:\/\/medicalxpress.com\/tags\/cancer\/\" rel=\"tag\" class=\"\">cancer<\/a>.The drug is now being developed in early phase clinical trials to determine its safety in people with advanced cancer.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cancer Research UK scientists have invented a new experimental drug that aims to harness the full power of the body\u2019s own immune system, launching a two-pronged response against cancer, according to a study published in Nature Cancer today. In the study, partly funded by Cancer Research UK, the new immunotherapy drug, which targets suppressive \u2018regulatory\u2019 [\u2026]<\/p>\n","protected":false},"author":591,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-115904","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/115904","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/591"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=115904"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/115904\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=115904"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=115904"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=115904"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}